Strategy of eye function protection for advanced nasal sinus malignant tumor patients

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-14004984

Enrollment

Unknown

Registered

2014-07-15

Start date

2012-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal sinus malignant tumor

Interventions

A:preoperative autologous tissue remoed at the time of induction chemotherapy, large scale hard wall reconstruction, postoperative chemoradiation orbital wall

B:traditional pattern of "radiotherapy plus surgery

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: advanced nasal sinus malignant tumor patients

Exclusion criteria

Exclusion criteria: Recurrent patients; the body condition is not fit for the treatment.

Design outcomes

Primary

Measure	Time frame
the survival rate of hree years;function of eyes;	—

Countries

China

Contacts

Public ContactXiaohong Cheng

trchxh@163.com+86 13911071002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026